Evidence map›Paper›PMID 33792456›Full record

ArticleChronobiology international2021

Performance of Fitbit Charge 3 against polysomnography in measuring sleep in adolescent boys and girls.

Luca Menghini, Dilara Yuksel, Aimee Goldstone, Fiona C Baker, Massimiliano de Zambotti

Open access · greenAbstract read
In one paragraph

Article in Chronobiology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Assessment of Fitbit Charge 4 for sleep stage and heart rate monitoring against polysomnography and during home monitoring in Huntington's disease.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024
    Article
  13. Review
  14. Article
  15. Resident Sleep During Traditional Home Call Compared to Night Float.Journal of academic ophthalmology (2017) · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 3 countries.

Luca MenghiniCenter for Health Sciences, SRI International, Menlo Park, California, USA.ORCID 0000-0001-6494-3970
Dilara YukselCenter for Health Sciences, SRI International, Menlo Park, California, USA.ORCID 0000-0001-6183-8307
Aimee GoldstoneCenter for Health Sciences, SRI International, Menlo Park, California, USA.ORCID 0000-0003-2459-4790
Fiona C BakerCenter for Health Sciences, SRI International, Menlo Park, California, USA.ORCID 0000-0001-9602-6165
Massimiliano de ZambottiCenter for Health Sciences, SRI International, Menlo Park, California, USA.ORCID 0000-0002-0057-5977
SRI International · US

Funding

Sleep and Cardiovascular Health in AdolescenceR01HL139652 · NHLBI · SRI INTERNATIONAL · PI DE ZAMBOTTI, MASSIMILIANO · 2018 to 2021
$2.9M
NHLBI NIH HHS R01 HL139652
6 · The paper itself

Abstract

We evaluated the performance of Fitbit Charge 3™ (FC3), a multi-sensor commercial sleep-tracker, for measuring sleep in adolescents against gold-standard laboratory polysomnography (PSG). Single-night PSG and FC3 sleep outcomes were compared in thirty-nine adolescents (22 girls; 16-19 years), 12 of whom presented with clinical/subclinical DSM-5 insomnia symptoms (7 girls). Discrepancy analysis, Bland-Altman plots, and epoch-by-epoch analyses were used to evaluate FC3 performance. The influence of several factors potentially affecting FC3 performance (e.g., sex, age, body mass index, firmware version, and magnitude of heart rate changes between consecutive PSG epochs) was also tested. In the sample of healthy adolescents, FC3 systematically underestimated PSG total sleep time by about 11 min and sleep efficiency by 2.5%, and overestimated wake after sleep onset by 9 min. Proportional biases were detected for "light" and "deep" sleep duration, resulting in significant underestimation of these parameters for those participants having longer PSG N1+ N2 and N3 durations, respectively. No significant systematic bias was detected for sleep efficiency and sleep onset latency. Epoch-by-epoch analysis showed sleep-stage sensitivity (average proportion of PSG epochs correctly classified by the device for a given sleep stage) of 68% for wake, 78% for "light" sleep, 59% for "deep" sleep, and 69% for rapid eye movement (REM) sleep in healthy sleepers. Similar results were found in the sample of adolescents with insomnia symptoms. Body mass index was positively associated with FC3-PSG discrepancies in wake after sleep onset (R

Indexed as

Circadian RhythmSleepActigraphyAdolescentFemaleFitness TrackersHumansMalePolysomnographyReproducibility of Resultsaccuracyadolescenceconsumer sleep technologyFitbitinsomniaWearable sleep trackers

Identifiers

PMID33792456
PMCPMC8255273
OpenAlexW3151917753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.